Beijing Community Diabetes Study

Conditions

Diabetes

Xuelian Zhang, Shen-Yuan Yuan, Gang Wan, Mingxia Yuan, Guang-Ran Yang et al. (14 authors)

Scientific Reports2021-03-0110 citations

Improved Framingham Risk Scores of Patients with Type 2 Diabetes Mellitus in the Beijing Community: A 10-Year Prospective Study of the Effects of Multifactorial Interventions on Cardiovascular Risk Factors (The Beijing Communities Diabetes Study 22).

Zhang XL, Wan G, Yuan MX, Yang GR, Fu HJ, Zhu LX, Xie RR, Lv YJ, Zhang JD, Li YL, Dai QF, Ji Y, Holman RR, Yuan SY, Beijing Communities Diabetes Study Group.

2020-02-215 citations

10.1007/s13300-020-00782-5

Analysis of the Effect of Nine Consecutive Years’ Intensive Management and Number of Times Achieving the Target Control on Endpoint Events in T2DM Patients in Sanlitun Community Health Service Center in Beijing

Chen-Mei Zhao, Xueli Cui, Gang Wan, Yu-Zhe Lu, Yuqin Niu et al. (22 authors)

International Journal of Endocrinology2020-02-204 citations

10.1155/2020/3646342

The effects of cardiovascular risk factor combined anti-platelet therapy and the risk of cerebrovascular events in patients with T2DM in an urban community over 96-months follow-up: The Beijing communities diabetes study 19.

Zhang XL, Fu HJ, Yang GR, Wan G, Li D, Zhu LX, Xie RR, Lv YJ, Zhang JD, Li YL, Dai QF, Ji Y, Gao DY, Cui XL, Liu DY, Yuan SY, Yuan MX, Beijing Communities Diabetes Study Group.

2018-09-133 citations

10.1016/j.diabres.2018.09.007

Interventions

Intervention Group:Lifestyle education+Peer Support Groups+Electronic tracking and decision support+drug therapy adjustmen

control group:lifestyle advice and drug therapy

Eligibility

Sex/Gender

All

Age

30 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. T2DM; 2. >30yrs when diagnosed,residents of the community; 3. Aged 30-80 years old; 4. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Residential mobility, difficult to be regular follow-up; 2. Severe movement disorder; 3. Poor compliance; 4. Long-term oral corticosteroids; 5. 2.5 times greater than normal ALT; 6. Serum creatinine greater than 200umol/L; 7. Moderate, and severe schizophrenia; 8. Those who are participating in other clinical trials; 9. Those who are considered by the doctors as appropriate to participate.

Design outcomes

Primary

Measure	Time frame
HbA1c;blood pressure;Lipids;BMI;	—

Secondary

Measure	Time frame
UAER;Diabetic Retinopathy;CVD;	—

Countries

China

Contacts

Public ContactMINGXIA YUAN

Beijing Tongren Hospital

yuanmx@vip.126.com+86 13910184427

Outcome results

None listed